Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working"
- PMID: 17848654
- DOI: 10.1001/jama.298.10.1196
Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working"
Abstract
Nausea and vomiting, symptoms that occur commonly near the end of life, represent a substantial source of physical and psychological distress for patients and families. In the context of the case of Mr Q, a 50-year-old man with metastatic esophageal cancer admitted to the hospital with intractable nausea and vomiting, we review the evaluation and treatment of this symptom complex. A thorough history and physical examination are essential first steps in the management of these patients because they define the severity of the symptoms and clues to their underlying etiology. Once the most likely cause is determined, the clinician discerns the mechanism, specific transmitters, and receptors by which this etiology is triggering nausea and vomiting. Subsequent pharmacological management focuses on prescribing the appropriate antagonist to the implicated receptors. If symptoms are refractory despite adequate dosage and around-the-clock prophylactic administration, an empirical trial combining several therapies to block multiple emetic pathways should be attempted. Less traditional agents are also discussed, although evidence for their use is limited. Often, oral administration of medication is not feasible and alternate routes such as rectal suppositories, subcutaneous infusions, and orally dissolvable tablets should be considered. Using this step-wise approach, nausea and vomiting can be successfully managed in most patients at the end of life.
Comment in
-
Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working".JAMA. 2008 Apr 16;299(15):1826. doi: 10.1001/jama.299.15.1826. JAMA. 2008. PMID: 18413877 No abstract available.
Similar articles
-
Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working".JAMA. 2008 Apr 16;299(15):1826. doi: 10.1001/jama.299.15.1826. JAMA. 2008. PMID: 18413877 No abstract available.
-
The management of nausea and vomiting in advanced cancer.Int J Palliat Nurs. 2011 Jul;17(7):321-7. doi: 10.12968/ijpn.2011.17.7.321. Int J Palliat Nurs. 2011. PMID: 21841700
-
Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.Jpn J Clin Oncol. 2010 Aug;40(8):739-45. doi: 10.1093/jjco/hyq048. Epub 2010 Apr 21. Jpn J Clin Oncol. 2010. PMID: 20410056 Clinical Trial.
-
Understanding nausea and vomiting in advanced cancer.Nurs Times. 2005 Jan 25-31;101(4):32-5. Nurs Times. 2005. PMID: 15719789 Review.
-
[Managing nausea and vomiting in thoracic oncology].Rev Pneumol Clin. 2008 Apr;64(2):76-80. doi: 10.1016/j.pneumo.2008.04.001. Epub 2008 Jun 6. Rev Pneumol Clin. 2008. PMID: 18589287 Review. French.
Cited by
-
Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review.J Clin Med. 2024 Mar 29;13(7):1991. doi: 10.3390/jcm13071991. J Clin Med. 2024. PMID: 38610755 Free PMC article. Review.
-
Anxiety and depression disorders in oncological patients under palliative care at a hospital service: a cross-sectional study.BMC Palliat Care. 2023 Aug 15;22(1):116. doi: 10.1186/s12904-023-01233-1. BMC Palliat Care. 2023. PMID: 37580770 Free PMC article.
-
Nonsurgical Treatment Strategies for Elderly Head and Neck Cancer Patients: An Emerging Subject Worldwide.Cancers (Basel). 2022 Nov 19;14(22):5689. doi: 10.3390/cancers14225689. Cancers (Basel). 2022. PMID: 36428780 Free PMC article. Review.
-
Postoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelines.World J Emerg Surg. 2022 Sep 21;17(1):50. doi: 10.1186/s13017-022-00455-7. World J Emerg Surg. 2022. PMID: 36131311 Free PMC article. Review.
-
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2021 Apr 1;19(1):51. doi: 10.1186/s12969-021-00539-9. Pediatr Rheumatol Online J. 2021. PMID: 33794950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
